10th European Medical Information and Communications Conference and Exhibition

29 - 30 November 2016, Berlin, Germany
The 10th year of the Annual European Medical Information and Communications Conference is a unique meeting organised by medical information professionals for medical information professionals. Each year, speakers share hands-on experience dealing with current challenges as well as successes in medical information departments. Participants are encouraged to take part in the interactive workshop sessions and discussions happening throughout the conference. This conference is the one and only European forum dedicated to medical information and communications, making it the premier opportunity to network, exchange learnings, and share best practices.

Key Topics

  • Moving from traditional phone- and email-based channels to innovative digital channels to disseminate medical information
  • Examples of successes in digital presented by the most advanced players
  • Comparison between pharmaceuticals and medical devices - can the same strategies be used, or is a different approach needed?
  • Regulatory and legal issues: developments since the rejection of Safe Harbor - what's the impact of the new data privacy rules in Europe (Data privacy shield)
  • How to optimise collaboration between MSL and MedInfo roles
  • Effects of globalisation on different roles? How much localisation and how much globalisation is suitable?

Join the Annual European Medical Information and Communications Conference and find answers to issues of daily importance:

  • Are you clear on how to handle questions about off-label use?
  • Do you understand the latest changes in data privacy regulations?
  • Do you know the pros and cons of outsourcing medical information services?
  • How do you ensure high quality when you outsource customer service? Are you not happy with the quality of your outsourced customer services?
  • Is quality an issue in your outsourced medical information function?
  • Is your medical information website getting high enough usage? Learn how to improve hits and increase the number of users.
  • You have develop a website for customer service - now how do you get people to use your site? Is all your effort of building the site going to waste because nobody uses it?
  • How can you be successful in globalising medical information? From a local perspective, how can you best adapt and implement global guidelines?

Call for Poster Abstracts
Become an active part of the conference you attend by presenting a poster. Submit an abstract and take this opportunity to present your research and work to your peers at the conference. It's the perfect place for you to put your research into the limelight, to create discussions around your results with other professionals or to generate interest around a subject you feel needs more attention.

The European Medical Information and Communication Conference stretches across a variety of topics that you have encountered during your work. Contribute to the discussions at the conference by sharing your own experience. Please only submit abstracts matching the following topics:

  • From Safe Harbor to The EU/US Privacy Shield - What do you Need to Know in Medical Information?
  • The Future of Medical Information - Changing Modes of Communication
  • Globalization/Regionalization - Is it Possible to Have one Framework?
  • Medical Information and Medical Scientific Liaisons (MSLs) Partnerships
  • Providing Medical Information for Medical Devices
  • When Medical Information Goes On-line - Optimising the Sharing Experience
  • Considerations, User-Interface and Other Considerations
  • Supporting Established Products in Medical Information
  • Outsourcing and Insourcing Medical Information
  • Medical Information for Challenging Geographies

Deadline: Submit Poster Abstracts by Monday, 26 September 2016.

For further information, please visit:
http://www.diaglobal.org/en/conference-listing/meetings/2016/11/10th-annual-european-medical-information-and-communications-conference-and-exhibition

About DIA
For over 50 years, DIA has served as a global platform for more than 30,000 health care product development professionals, researchers, regulators, clinicians, academics and patient advocates to collaborate to improve health globally through the advancement of lifesaving medicines and technologies. As the premier professional community for the health care product development ecosystem, DIA (the Drug Information Association) provides global players a neutral and transparent forum for the exchange of ideas and collaboration. By offering access to tools, resources, and networking opportunities, DIA provides its members and international participants objective opportunities for extending debate and discussion to advance scientific and medical innovation.

DIA is an independent, global nonprofit organization based in Washington, DC, USA, with regional offices representing the Americas (Horsham, PA, USA); Europe, the Middle East, and Africa (Basel, Switzerland); and Asia (Beijing, China; Mumbai, India; and, Tokyo, Japan).

Most Popular Now

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 vaccine (COMIRNATY® Original/Om...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...

WHO grants prequalification to GSK's Mosquirix - t…

GSK plc (LSE/NYSE: GSK) announced that the World Health Organization (WHO) has awarded prequalification to Mosquirix (also known as RTS,S/AS01), GSK's groundbreaking mala...

Bird's enzyme points toward novel therapies

Thank the rare crested ibis for a clue that could someday help our bodies make better drugs. The species of bird is the only one known to naturally produce an enzyme ...

WHO strongly advises against antibody treatments f…

The antibody drugs sotrovimab and casirivimab-imdevimab are not recommended for patients with COVID-19, says a WHO Guideline Development Group of international experts in...